ICU Medical raises FY25 EPS view to $7.35-$7.65 from $6.85-$7.15

Consensus $6.99. The company said, “For Fiscal Year 2025 the Company is updating its estimates of GAAP net loss from a range of $(43) million to $(35) million to a range of $(8) million to $0 million and GAAP diluted loss per share from a range of $(1.68) to $(1.38) to a range of $(0.30) to $0.00. The Company is updating the estimate of the range of its full year 2025 guidance of adjusted EBITDA from a range of $380 million to $390 million to a range of $395 million to $405 million and diluted earnings per share from a range of $6.85 to $7.15 to a range of $7.35 to $7.65.”